Regeneron (REGN) Tops Q4 EPS by 109c

Regeneron (NASDAQ: REGN) reported Q4 EPS of $11.86, $1.09 better than the analyst estimate of $10.77. Revenue for the quarter came in at $3.43 billion versus the consensus estimate of $3.3 billion.

For earnings history and earnings-related data on Regeneron (REGN) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
• Algorhythm Holdings (RIME) Tops Q2 EPS by 54c